Tetanus vaccination is associated with decreased incidence of Parkinson’s disease and slower progression

People who have had a recent vaccine against tetanus appear to be less likely to develop Parkinson’s disease, suggesting that the bacterial infection is involved in the condition. In this study, we used a new machine learning method to look at how vaccines and medications affect PD. We found that getting a tetanus vaccine can significantly lower the chances of getting PD. The severity of PD is also linked to how long it's been since the last tetanus shot. This suggests that the toxin from the bacteria causing tetanus might be involved in PD. Tetanus vaccination and treatments that target certain bacteria could help prevent PD and slow its progression, but more controlled trials are needed to confirm this. PD affects over six million people worldwide and is caused by the loss of brain cells. It's diagnosed by symptoms like tremors and slow movement, often starting after age 45. Currently, only exercise has been shown to slow its progression. Clostridium bacteria, including the type that causes tetanus, produce powerful toxins. These bacteria are common in the environment and can be found in the human gut. The tetanus toxin affects nerve function and might be linked to PD. Regular tetanus vaccinations might reduce the risk of developing PD, especially since PD often appears when vaccine protection from childhood has worn off. Recent research shows differences in gut bacteria between people with PD and those without, with changes particularly noted in Clostridium species. This connection suggests that tetanus and other Clostridium bacteria might play a role in PD, indicating that vaccines and antimicrobial treatments targeting these bacteria could be beneficial.